Regorafenib
Clinical trials for Regorafenib explained in plain language.
Never miss a new study
Get alerted when new Regorafenib trials appear
Sign up with your email to follow new studies for Regorafenib, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug cocktail aims to wipe out hidden colorectal cancer cells
Disease control Recruiting nowThis phase 2 trial tests two drugs, regorafenib and lorigerlimab, in people with high-risk colorectal cancer who have no visible tumors but still have cancer DNA in their blood after standard treatment. The goal is to see if the combination can clear these hidden cancer cells and…
Matched conditions: REGORAFENIB
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
New immune combo tackles Hard-to-Treat colorectal cancer
Disease control Recruiting nowThis early-phase trial tests a combination of three treatments for advanced colorectal cancer that has not responded to standard therapies. The approach uses the patient's own immune cells (DC-CIK), a targeted drug (regorafenib), and a bispecific antibody to boost the immune syst…
Matched conditions: REGORAFENIB
Early phase 1 • Sponsor: JIANG LONGWEI • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC